Data / Drug companies / Demoulas Super Markets, Inc
Demoulas Super Markets, Inc: 63 products in the FDA NDC directory, labeler code 53942
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Demoulas Super Markets, Inc (labeler code 53942) lists 63 products in the FDA National Drug Code Directory, covering 25 finished drugs by generic name. By type: 63 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 26, 2026.
The request: Watch Demoulas Super Markets, Inc (FDA labeler code 53942): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 53942
- Products in commercial distribution
- 63
- Packages
- 85
- Finished drugs by generic name
- 25
- Prescription products
- 0
- Over the counter products
- 63
- Flagged as original packager
- 42 of 42 products that carry the flag
- Started marketing in the last 12 months
- 6
- Earliest marketing start
- July 15, 1989
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 54 | 85.7% |
| Generic drugs (ANDA) | 9 | 14.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 63 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 11 | 17.5% |
| Mouthwash | 9 | 14.3% |
| Tablet, chewable | 6 | 9.5% |
| Tablet, coated | 6 | 9.5% |
| Suspension | 5 | 7.9% |
| Tablet, extended release | 3 | 4.8% |
| Shampoo | 3 | 4.8% |
| Aerosol, spray | 3 | 4.8% |
| Solution | 3 | 4.8% |
| Spray | 2 | 3.2% |
| Tablet | 2 | 3.2% |
| Gel | 2 | 3.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| 8HR Arthritis Pain | 53942-200 | Tablet, extended release | Generic drugs (ANDA) | October 26, 2026 |
| Market Basket Effervescent Antacid and Pain Relief | 53942-421 | Tablet, effervescent | Over the counter monograph drugs | April 3, 2026 |
| CHILDRENS PAIN RELIEVER and FEVER REDUCER GRAPE | 53942-526 | Suspension | Over the counter monograph drugs | January 1, 2026 |
| CHILDRENS PAIN RELIEVER and FEVER REDUCER CHERRY | 53942-525 | Suspension | Over the counter monograph drugs | January 1, 2026 |
| DM Max CONGESTION and COUGH | 53942-518 | Solution | Over the counter monograph drugs | January 1, 2026 |
| SEVERE CONGESTION and COUGH MAX | 53942-517 | Solution | Over the counter monograph drugs | January 1, 2026 |
| Allergy Relief | 53942-190 | Tablet, coated | Over the counter monograph drugs | July 16, 2025 |
| Pain Relief | 53942-170 | Tablet, coated | Over the counter monograph drugs | July 16, 2025 |
| Ibuprofen | 53942-112 | Tablet, coated | Generic drugs (ANDA) | July 16, 2025 |
| Pain Relief | 53942-092 | Tablet, coated | Over the counter monograph drugs | July 16, 2025 |
| Ultra Strength Antacid Assorted Fruit | 53942-171 | Tablet, chewable | Over the counter monograph drugs | March 5, 2025 |
| Extra Strength Antacid Tropical Fruit | 53942-129 | Tablet, chewable | Over the counter monograph drugs | March 4, 2025 |
| Extra Strength Antacid Assorted Fruit | 53942-128 | Tablet, chewable | Over the counter monograph drugs | March 4, 2025 |
| Extra Strength Assorted Berry Antacid | 53942-127 | Tablet, chewable | Over the counter monograph drugs | March 4, 2025 |
| Regular Strength Antacid | 53942-126 | Tablet, chewable | Over the counter monograph drugs | March 4, 2025 |
| Regular Strength Peppermint Antacid | 53942-113 | Tablet, chewable | Over the counter monograph drugs | March 4, 2025 |
| Acid Reducer | 53942-443 | Tablet | Generic drugs (ANDA) | November 30, 2023 |
| Market Basket Effervescent Pain Relief | 53942-883 | Tablet, effervescent | Over the counter monograph drugs | October 18, 2023 |
| Eucalyptol, menthol, methyl salicylate, thymol | 53942-855 | Mouthwash | Over the counter monograph drugs | June 5, 2023 |
| Sodium fluoride | 53942-581 | Mouthwash | Over the counter monograph drugs | June 5, 2023 |
| Mucus Relief Maximum Strength | 53942-204 | Tablet, extended release | Generic drugs (ANDA) | October 1, 2022 |
| Mucus Relief | 53942-203 | Tablet, extended release | Generic drugs (ANDA) | October 1, 2022 |
| Anticavity | 53942-971 | Rinse | Over the counter monograph drugs | April 4, 2022 |
| Ibuprofen | 53942-381 | Tablet, coated | Generic drugs (ANDA) | January 30, 2022 |
| Market Basket Continuous Sunscreen General Protection SPF 70 | 53942-007 | Spray | Over the counter monograph drugs | November 2, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.